Personal HistoryMatthew R. Weir, MD, is attending physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital, Baltimore. He is also Professor of Medicine at the University of Maryland School Of Medicine.Dr. Weir’s primary research interests include the use of antihypertensive therapy for the treatment of diabetic nephropathy, hypertensive renal injury in African Americans, and preventing allograft nephropathy in transplant recipients. He has written more than 400 manuscripts and book chapters about these topics. He has edited two books: “Medical Management of Kidney Transplantation” and “Hypertension”. He has presented at numerous international scientific association meetings, hospitals, and medical schools. Dr. Weir currently reviews manuscripts for more than 20 major medical journals, including the American Journal of Kidney Disease, the Journal of the American Society of Nephrology, and Archives of Internal Medicine. He is on the editorial board of eight journals and is Section Editor of Current Hypertension Reports and Current Opinion in Hypertension and Nephrology. He has three active NIH supported grants from NIDDK. In addition, he is a member of numerous associations, including the American Society of Nephrology, the National Kidney Foundation, the American Heart Association, and the American Society of Transplantation. Dr. Weir received his medical degree from the University of Virginia, Charlottesville. He completed his internship and residency programs in medicine at the Waterbury and Yale-New Haven Hospitals in Connecticut, and completed his nephrology training at the Brigham and Women’s Hospital, Harvard Medical School, in Boston, Massachusetts. He then moved to the University of Maryland where he has been a full time faculty member since 1983. Research InterestsMy primary research interest focus is on cardiovascular disease associated with chronic kidney disease. Our group is involved in a series of clinical trials to evaluate biomeasures of cardiovascular disease in patients with chronic kidney disease as well as to better describe optimum levels of blood pressure and use of various antihypertensive medications in delaying progression of kidney disease. These studies are ongoing in patients with non-diabetic as well as diabetic native kidney disease. In addition, we have ongoing trials to evaluate the etiologies of cardiovascular disease and progressive loss of kidney function in patients who have received kidney transplants. These data are important in order to evaluate optimal means of preventing cardiovascular disease in kidney transplant recipients, as well as better forms of immunosuppression to limit the development of allograft nephropathy and ultimately graft loss.Clinical SpecialityCardiovascular disease associated with chronic kidney disease and prevention of progressive renal disease.Publications
|
